IPO7 and cervical carcinoma: Studies in cervical and pancreatic cancers indicate that elevated IPO7 expression correlates with poor prognosis and decreased CD8 T cell infiltration in cervical cancer and adverse outcomes in pancreatic cancer patients [50,51].